Fishman Jay A LTD Bausch Health Companies Inc. Transaction History

Fishman Jay A LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$21.6 - $27.79 $204,120 - $262,615	-9,450 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $69,000 - $87,030	-3,000 Reduced 24.1%	9,450 $260,000
Q3 2021 Nov 08, 2021	SELL	$25.04 - $30.06 $180,288 - $216,432	-7,200 Reduced 36.64%	12,450 $346,000
Q2 2021 Aug 09, 2021	SELL	$27.43 - $32.7 $336,017 - $400,575	-12,250 Reduced 38.4%	19,650 $576,000
Q4 2020 Feb 10, 2021	SELL	$15.31 - $21.12 $113,294 - $156,288	-7,400 Reduced 18.83%	31,900 $663,000
Q3 2020 Nov 10, 2020	SELL	$14.88 - $20.13 $723,168 - $978,318	-48,600 Reduced 55.29%	39,300 $610,000
Q2 2020 Aug 10, 2020	SELL	$13.31 - $20.51 $66,550 - $102,550	-5,000 Reduced 5.38%	87,900 $1.61 Million
Q1 2020 May 13, 2020	BUY	$12.98 - $30.25 $1.21 Million - $2.81 Million	92,900 New	92,900 $1.44 Million

270

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.54B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

Stay updated on Fishman Jay A LTD with notifications on news.